Non-invasive Glioma Characterization Through Molecular Imaging
Launched by UNIVERSITY OF MIAMI · Sep 21, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to understand brain tumors called gliomas. Researchers are using special MRI scans to measure certain chemicals and the structure of the tumor without needing to do surgery. By learning more about these tumors, the hope is to develop better treatments for patients with gliomas.
To participate in this trial, you need to be an adult (18 years or older) who has a suspected or confirmed glioma and is scheduled for a biopsy or surgery for the tumor. Unfortunately, if you are pregnant, unable to give your consent, or cannot have an MRI, you will not be eligible. Participants can expect to undergo MRI scans as part of their regular care, which will help researchers gather important information about the tumor. This study is currently recruiting participants, and everyone is welcome to join, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (≥18 year old)
- • Subjects with suspected or confirmed gliomas and who will have a medically indicated biopsy or resection of his/her brain lesion.
- Exclusion Criteria:
- • Adults unable to consent
- • Individuals who are not yet adults (infants, children, teenagers)
- • Pregnant women
- • Patients unable to have MRI done
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Patients applied
Trial Officials
Macarena De La Fuente, MD
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials